CCG-203971

CAS : 1443437-74-8

Ref. TM-T4306

Informations sur le produit

• Nom: CCG-203971
• Synonymes: CCG203971
• CAS: 1443437-74-8

Description

CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM. This compound also inhibits PC-3 cell migration (IC50: 4.2 μM), as determined by a scratch wound assay. CCG-203971(CCG203971) causes no cytotoxicity when evaluated by the WST-1 assay. It is well tolerated in normal mice up to doses of 100 mg/kg given intraperitoneally over five days.

• Marque: Targetmol

Propriétés chimiques

• Masse moléculaire: 408.88
• Formule: C₂₃H₂₁ClN₂O₃
• Degré de pureté: 99.35%
• Couleur/Forme: Solid